Healthy Skepticism Library item: 4140
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
Re: the promotion of sulbutiamine
1990 Apr
Abstract:
Servier’s subsidiary in Saudi Arabia is marketing sulbutiamine (Arcalion 200) for a variety of vague psychological conditions despite the absence of any clinical trials to support its use.
Keywords:
*analysis/Saudi Arabia/developing countries/sulbutiamine/Arcalion 200/Servier/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES